WHO Firmly Rejects Trump's Controversial Paracetamol-Autism Link Claim

The World Health Organization (WHO) has delivered a definitive rebuttal to claims made by former US President Donald Trump, who asserted that paracetamol (also known as acetaminophen) use during pregnancy could potentially lead to autism in children. The global health body unequivocally dismissed these suggestions, emphasizing the complete absence of scientific evidence to support such a dangerous connection.

Trump's comments, which garnered significant attention, were met with swift condemnation from medical and scientific communities worldwide.

The WHO, a leading authority on global health, highlighted the importance of relying on evidence-based information, especially concerning maternal and child health. Their stance reinforces the long-standing medical consensus that paracetamol, when used appropriately and within recommended dosages, remains a safe and effective pain reliever and fever reducer for expectant mothers.

Experts at the WHO pointed out that extensive research and numerous studies over decades have consistently failed to establish any causal link between paracetamol use during pregnancy and the development of autism spectrum disorder.

Autism is a complex neurodevelopmental condition with various contributing genetic and environmental factors, none of which have been credibly associated with this commonly used medication.

This intervention by the WHO serves as a critical reminder of the potential harm caused by unsubstantiated health claims, particularly when propagated by influential figures.

Such misinformation can lead to unnecessary anxiety among pregnant women, potentially discouraging them from using a safe medication when needed, and in some cases, prompting them to opt for less safe alternatives or endure untreated pain and fever, which could pose risks to both mother and fetus.

The WHO advises pregnant individuals to always consult with their healthcare providers regarding any medications, including over-the-counter drugs, to ensure safety and appropriateness.

They reiterate that healthcare decisions should be guided by robust scientific evidence and professional medical advice, not by unverified public statements or social media speculation.